Blepharoplasty Market Report 2026
Global Outlook – By Type (Upper Eyelid Blepharoplasty, Lower Eyelid Blepharoplasty, Combination Eyelid Surgery), By Gender (Female, Male), By End-User (Hospitals, Clinics, Ambulatory Surgical Centre, Other End-Users) - Market Size, Trends, Strategies, and Forecast to 2030
Blepharoplasty Market Overview
• Blepharoplasty market size has reached to $4.54 billion in 2025 • Expected to grow to $6.89 billion in 2030 at a compound annual growth rate (CAGR) of 8.9% • Growth Driver: Impact Of Renal Disease Prevalence On The Blepharoplasty Market • Market Trend: Innovative Advancements In Plasma Technology Transforming The Blepharoplasty Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Blepharoplasty Market?
Blepharoplasty is a surgical procedure that improves the appearance of the eyelids by removing excess skin, muscle, and fat from the upper and lower eyelids. It is performed for cosmetic and functional purposes to improve eye aesthetics and address vision impairment due to drooping eyelids. The main types of blepharoplasty are upper eyelid blepharoplasty, lower eyelid blepharoplasty, and combination eyelid surgery. Upper eyelid blepharoplasty refers to a surgical procedure to remove excess skin, muscle, and fat from the upper eyelids to rejuvenate the appearance of the upper eyelids by removing excess tissue and creating a more refreshed look. Blepharoplasty is performed on both female and male gender types by end-users such as hospitals, clinics, ambulatory surgical centers, and others.
What Is The Blepharoplasty Market Size and Share 2026?
The blepharoplasty market size has grown strongly in recent years. It will grow from $4.54 billion in 2025 to $4.9 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increasing aesthetic awareness, rising aging population seeking eyelid correction, availability of skilled cosmetic surgeons, expansion of ambulatory surgical centers, growing acceptance of cosmetic procedures.What Is The Blepharoplasty Market Growth Forecast?
The blepharoplasty market size is expected to see strong growth in the next few years. It will grow to $6.89 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing adoption of advanced surgical technologies, rising demand for combined cosmetic and functional procedures, expansion of outpatient and day-care surgeries, growing focus on patient safety and recovery outcomes, increasing integration of digital surgical planning tools. Major trends in the forecast period include advancements in minimally invasive surgical techniques, growing demand for cosmetic facial procedures, rising adoption of laser-assisted surgeries, enhanced focus on functional vision correction, expansion of outpatient surgical services.
Global Blepharoplasty Market Segmentation
1) By Type: Upper Eyelid Blepharoplasty, Lower Eyelid Blepharoplasty, Combination Eyelid Surgery 2) By Gender: Female, Male 3) By End-User: Hospitals, Clinics, Ambulatory Surgical Centre, Other End-Users Subsegments: 1) By Upper Eyelid Blepharoplasty: Traditional Upper Eyelid Surgery, Laser Upper Eyelid Surgery 2) By Lower Eyelid Blepharoplasty: Transconjunctival Lower Eyelid Surgery, Traditional Lower Eyelid Surgery 3) By Combination Eyelid Surgery: Upper And Lower Eyelid Surgery Together, Eyelid Surgery With Other Facial ProceduresWhat Is The Driver Of The Blepharoplasty Market?
The increasing prevalence of renal disease is expected to propel the growth of the blepharoplasty market going forward. Renal disease, or chronic kidney disease (CKD), is a medical condition characterized by gradually losing kidney function. Renal disease can contribute to eye puffiness and altered eyelid positions, and patients with renal disease should have their renal function checked before undergoing blepharoplasty surgery. For instance, in May 2023, according to the National Institutes of Health, the primary agency of the United States government responsible for biomedical and public health research, approximately 808,000 individuals in the United States are currently dealing with end-stage renal disease (ESRD), also referred to as ESKD, with 69% undergoing dialysis and 31% having received a kidney transplant. Therefore, the increasing prevalence of renal disease is driving the growth of the blepharoplasty industry.Key Players In The Global Blepharoplasty Market
Major companies operating in the blepharoplasty market are Zimmer Biomet Holdings Inc., Cynosure Technologies Pvt Ltd., Galderma SA, Bausch & Lomb Incorporated, Allergan Inc, Integra LifeSciences Inc., Merz Pharma GmbH & Co. KGaA, Corza Ophthalmology, Lumenis Ltd., Cutera Inc., Stille AB, Alma Lasers Ltd, Sciton Inc, Beaver-Visitec International Holdings Inc., Sklar Surgical Instruments, Hayden Medical Inc, Gulmaher Surgico, Luminera Derm Ltd, Jedmed Instrument Company, Xelpov Surgical, Surgitrac Instruments UK Limited, Surgical Holdings, Surgipro Inc., LightScalpel Inc., SPIRAL Surgical Co., Carnegie Surgical LLC., Ambler Surgical LLC
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Blepharoplasty Market Trends and Insights
Major companies operating in the blepharoplasty market are focusing on development of advanced technologies such as plasma technology to gain the strong position in the market. Plasma technology refers to the use of ionized gases, or plasmas, in a specialized medical device to perform non-surgical skin tightening and rejuvenation around the eyelids and other areas of the face. For instance, in January 2023, Apyx Medical Corporation, a US-based advanced energy technology company, launched the latest-generation Renuvion generator, the Apyx One Console. It is a multifunctional energy system designed for plastic and cosmetic surgeries by incorporating Renuvion technology (helium plasma and radiofrequency technology) along with monopolar and bipolar energy options. The console features adaptive touchscreens, procedural presets, cloud connectivity, remote upgrade capabilities, gas volume monitoring, and other advanced features that improve cosmetic surgical procedures, including eyelid surgery.What Are Latest Mergers And Acquisitions In The Blepharoplasty Market?
In February 2023, Athenix, a US-based medical practice company specializing in plastic surgery procedures, acquired Marina Plastic Surgery and MedSpa for an undisclosed amount. Athenix aims to expand its presence in the plastic surgery industry with this strategic acquisition and strengthen its service offerings. Athenix also demonstrates its commitment to providing comprehensive and innovative plastic surgery solutions, further establishing itself as a trusted provider in the industry. Marina Plastic Surgery and MedSpa is a US-based provider of plastic surgery services specializing in blepharoplasty procedures.
Regional Outlook
North America was the largest region in the blepharoplasty market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.Need data for a specific geography? Request Regional Data
What Defines the Blepharoplasty Market?
The blepharoplasty market consists of revenues earned by entities by providing transconjunctival blepharoplasty, canthoplasty, and revision blepharoplasty. The market value includes the value of related goods sold by the service provider or included within the service offering. The blepharoplasty market also includes sales of implants, eyelid cleansers and solutions, eyelid tape, and strips. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Blepharoplasty Market Report 2026?
The blepharoplasty market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the blepharoplasty industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Blepharoplasty Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $4.9 billion |
| Revenue Forecast In 2030 | $6.89 billion |
| Growth Rate | CAGR of 8.9% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Type, Gender, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain |
| Key Companies Profiled | Zimmer Biomet Holdings Inc., Cynosure Technologies Pvt Ltd., Galderma SA, Bausch & Lomb Incorporated, Allergan Inc, Integra LifeSciences Inc., Merz Pharma GmbH & Co. KGaA, Corza Ophthalmology, Lumenis Ltd., Cutera Inc., Stille AB, Alma Lasers Ltd, Sciton Inc, Beaver-Visitec International Holdings Inc., Sklar Surgical Instruments, Hayden Medical Inc, Gulmaher Surgico, Luminera Derm Ltd, Jedmed Instrument Company, Xelpov Surgical, Surgitrac Instruments UK Limited, Surgical Holdings, Surgipro Inc., LightScalpel Inc., SPIRAL Surgical Co., Carnegie Surgical LLC., Ambler Surgical LLC |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |